title: The year in non-ST-segment elevation acute coronary syndrome.
authors: TIMI Study Group, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
authors: Robert P
authors: RP
authors: Giugliano
authors: Eugene
authors: E
authors: Braunwald
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D000208:Acute Disease; D000367:Age Factors; D000368:Aged; D015415:Biomarkers / Q000378:metabolism; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D006328:Cardiac Catheterization / Q000592:standards; D002309:Cardiology / Q000379:methods / Q000592:standards / Q000639:trends*; D003327:Coronary Disease / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D004562:Electrocardiography; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D044882:Glucose Metabolism Disorders / Q000209:etiology / Q000628:therapy; D055436:Growth Differentiation Factor 15; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D017202:Myocardial Ischemia / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011785:Quality Assurance, Health Care / Q000379:methods; D000069458:Ranolazine; D018570:Risk Assessment / Q000379:methods; D012737:Sex Factors
chemical_list: D000083:Acetanilides; D015415:Biomarkers; D019485:Bone Morphogenetic Proteins; D004791:Enzyme Inhibitors; D005343:Fibrinolytic Agents; C526140:GDF15 protein, human; D055436:Growth Differentiation Factor 15; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010879:Piperazines; D000069458:Ranolazine